Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
In-licensing

Neurology Products

Treatments for neurological diseases

Full description

Amarin is looking to in-license compounds in development or on the market that address neurological diseases. Amarin intends to in-license compounds that it can ultimately market directly itself to neurologists and other specialists across the U.S.. In doing so Amarin will leverage its established reputation with the neurologist community, its experience and contacts.

Development status

Phase I

Type of business relationship sought

Co-development, in-licensing, strategic collaboration, acquisition.
Small trial ad
Bioiberica
EuroPLX 36 - Istanbul
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us